In-phase chest wall vibration (IPV) is knownto decrease dyspnea in patients with chronic obstructive pulmonary disease (COPD) at rest and during leg exercise. In the present study, the effects of IPV (100 Hz) on dyspnea and arm fatigue during upper extremity activity were studied in 9 patients with COPD(mean FEV1? 0.95 /). Dyspnea and arm fatigue (modified Borg scale) and ventilatory variables were measured during arm elevation (AE) with weights lifted straight above the head with and without IPV. Mean dyspnea during AE was 3.3 without IPV and 2.1 with IPV (p<0.05), but, arm fatigue, oxygen saturation and end-tidal Fco2 were not affected by IPV. Minute ventilation during AEwas significantly increased with IPV in 5 of 9 patients. The results suggest that IPV decreases dyspnea during AE.
Introduction
Both the mechanismand managementof dyspnea, in patients with chronic respiratory disease, remain unclear (1 , 2) . Regarding the managementof dyspnea, it has been reported that chest wall vibration modifies the sensation of dyspnea. In-phase vibration (IPV, vibration of the contracting intercostal muscle, namely the inspiratory intercostal muscle during the inspiratory phase and the expiratory intercostal muscle during the expiratory phase) decreases dyspnea induced in normal subjects (3) and in chronic obstructive pulmonary disease (COPD) patients at rest and during leg exercise (4, 5) . The alternate mode, ' outof-phase vibration' (vibration of the non-contracting intercostal muscle, namely the inspiratory intercostal muscle during the expiratory phase and the expiratory intercostal muscle during the inspiratory phase) increases dyspnea (4, 6) . The effect of IPV on dyspnea is hypothesized to involve stimulation of the muscle spindles, as IPV also increases tidal volume and decreases functional residual capacity, suggesting a tonic vibration reflex in the contracting intercostal muscles (4, 7, 8) .
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It has been shownthat unsupported arm exercise is more dyspnogenic than leg exercise in GOPDpatients (9, 10) . This is troublesome for the patients and decreases their quality of life, as activities of daily living often involve action of the upper extremities. Unsupported arm exercise causes the intercostal muscles to contract tonically, which maycause tonic firing of the intercostal muscle spindles. Celli et al have proposed that such tonic afferent signals maybe the cause of severe dyspnea (9) . In the present study, the effect of IPV on dyspnea, arm fatigue, ventilatory variables and blood gas during arm elevation (AE) in COPDpatients was evaluated.
Method
Nine patients (8 males, 1 female) with moderate to severe COPDwere studied (Table 1) . They were naive to IPV, and their mean ± SDage and forced expiratory volume in one second (FEV{) were 68 ± 6 year-old, and 0. respectively. Diagnosis was made according to standard criteria (1 1). They were receiving optimal medical therapy and were clinically stable at the time of the study. The study protocol was approved by the Showa University Ethics Committee and informed consent was obtained from all participants. Details of chest wall vibration are described in our previous reports (4, 6) . Twoupper vibrators, attached bilaterally at the second or third intercostal spaces in the parasternal region, were vibrated during the inspiratory phase, and two lower vibrators, attached bilaterally on the anterior axillary lines at the seventh to ninth intercostal spaces, were vibrated during the expiratory phase. At least 3 minutes were allowed between attachment of vibrators and the start of all measurements. The patients were asked to keep their arms straight above their head while holding weights (1-1.5 kg) for 3 minutes. AE was performed once without IPV and once with IPV. The trials were separated by at least a 15-minute rest and the sequence was random. The 1-minute measurementjust preceding the first AE was considered as the resting value. Dyspneaand arm muscle fatigue were evaluated verbally using amodifiedBorg (max 10) scale (12) each minute. AE was continued for 3 minutes and was stopped after the third evaluation or at the time whenthe patient wished to discontinue the trial. It was predetermined to terminate AEwhen the Borg scale reached 5, although this was not indicated to the patient prior to the study. Spo2 was recorded each minute by pulse oximetry 
Results
Seven of the nine patients completed both 3-minute trials of AE. One patient requested termination of both trials after two minutes, and both trials were terminated after one minute in the other patient because the dyspnea scale reached 5.
Results from a typical patient are shown in Fig. 1 . During the trial without IPV, dyspnea, arm fatigue and Ve increased with time. With IPV, the dyspnea rating was smaller, the fatigue rating remained unchanged, and Ve was larger than the trial without IPV. AE changed Spo2 from 97 to 96 without IPV and from 97 to 98 with IPV. Both are likely to be mere fluctuations and not significant changes. Changes in Fetco2 with AEand IPV also remained small. Overall changes are shown in Figs. 2 and 3. The mean ± SD dyspnea at the end ofAE was 3.3 ± 1.2 without IPV, and 2.1 ± 1.2 with IPV, which was significantly smaller (Wilcoxon paired test, p<0.05), but no significant difference was seen in arm fatigue (Fig. 2) . SpO2 did not decrease during either trial ofAE. Average Fetco2 at rest and at the end of AEwithout IPV and with IPV were 4.2, 4.4, and 4.3% respectively (Fig. 2) . IPV did not have any systematic effect on either Spo2 nor Fetco2 during AE. Individually in 3 cases, Fetco2 during AE with IPV was significantly lower than Fetco2 during AE without IPV (Student's t-test, p<0.05). The difference was, however, less than 0.2% in all 3 of the cases. Ve at the end of AEwas significantly (Student's t-test, p<0.05) greater with IPV compared to that without IPV in 5 patients (Fig. 3) . IPV significantly increased the tidal volume in one patient, and the respiratory rate in 3 patients. Overall, IPV did not affect Vo2 nor Vco2 during AE. AE significantly increased Vo2 (248.7 ± 40.6 ml/min at rest) to 324.0 ± 73.6 ml/ min without IPV and to 325.4 ± 72.3 ml/min with IPV. Vco2 (208.5 ± 34.6 ml/min at rest) was also increased to 264.8 ± 70.2 ml/min without IPV and to 268.7 ± 66.1 ml/min with IPV.
The results regarding dyspnea (Fig. 2) indicate that all 5 patients whose Borg rating was larger than average during AE without IPV had a lower Borg rating with IPV (4.2 ± 0.4 without 
Discussion
The results show that IPV decreased dyspnea during lifting weights straight above the head, but did not affect arm fatigue, oxygen saturation and end-tidal Fco2. Ve during the elevation was significantly increased with IPV in 5 of9 patients. Previous studies have also indicated that IPV decreases dyspnea (3) (4) (5) . The decrease in dyspnea observed in the present study could be due to a decrease in one or more of the following: 1) sensitivity in the sensory system, 2) central respiratory motor command (13, 14) , and 3) afferent signals from the respiratoryrelated receptors such as those in respiratory muscles, airway, lungs, and the chemoreceptors.
Sensory system
It is unlikely that IPV decreased dyspnea due to a reduction in the sensitivity in the sensory system. It has been shown that skin vibration increases pain threshold (15) . However, if sensory system sensitivity reduction was the principal reason for the decrease in AEdyspnea, a similar effect could have occurred for AEmuscle fatigue. This was not the case. Thus the reduction in AEdyspnea may be a morespecific effect of IPV.
Central motor command
The intensity of dyspnea has been shown to be closely related to the level of ventilation and metabolism ( 1 6). Thus, the relationship between ventilation and dyspnea is often investigated whenevaluating the effects of an intervention designed to relieve dyspnea. Reduction in Ve has been the proposed mechanism for decreased AEdyspnea after arm exercise training ( 10) . Vecould be a reflection of the central respiratory motorcommand; however, this reflection of the central respiratory motor commandby Ve may not be as good during IPV application compared to without IPV application. This is because IPV has been shownto elicit a spinal tonic vibration reflex, and increase muscle activation (7, 8 Figure 2 . Dyspnea, arm fatigue, arterial oxygen saturation (Spo2) and end-tidal Fco2 (Fetco2) at the end of arm elevation (AE) with and without in-phase vibration (IPV). Asterisk indicates significant difference (p<0.05). Dyspnea rating at rest was 0.6 ±0.8, and arm fatigue rating was 0 in all patients. Neither AEnor IPV had a significant effect on either Spo2 or during AEin 5 out of 9 patients, due to spinal tonic vibration reflex, the central respiratory motor commandmay have decreased, leading to a decrease in dyspnea.
Afferent signals It is unlikely that IPV decreased AEdyspnea chiefly due to a reduction in the chemical stimulation. Hypoxemiaand hypercapnia are thought to be related to dyspnea (2) . However, in the present study, the deterioration in blood gas with AEwas very slight, if any and it was unlikely to have been the cause of AE dyspnea. Also, there was no overall improvement in Spo2 during AE with IPV. A decrease in Fetco2 with IPV was observed in 3 patients, however as the decrease was less than 0.2% in all 3 patients, it was unlikely to have decreased AE dyspnea. Thus, improvement in blood gas is unlikely to be the principle reason for the decrease in AE dyspnea with IPV. The comparison between the 5 patients with strong AEdyspnea and 4 patients with slight AE dyspnea supports this conclusion. Interestingly, Spo2 at rest and during AEwith or without IPV in the patients with strong dyspnea was higher than in the patients with slight dyspnea. This indicates that desaturation was not the chief factor that determined AEdyspnea and also that improvement in desaturation can not explain the effect of IPV. The muscle spindles in the upper tonically active inspiratory muscles (9), may be powerfully stimulated when extended during the expiratory phase. Such afferents would be similar to those elicited by ' out-of-phase' vibration (4, 6), and are considered to be a possible cause ofAE dyspnea (9) . It is possible that IPV decreased such 'out-of-phase' afferents, as vibration applied to the expiratory intercostal muscle has been shownto inhibit inspiratory activity (7) . Also, increased firing from the contracting intercostal muscles might have decreased dyspnea as well (4) .
Vagal afferent signals from pulmonary mechanoreceptors have also been suggested to be involved in dyspnea (17, 18) . IPV could have stimulated the pulmonary mechanoreceptors either directly or due to the enhancedventilation. However,the role of vagal afferent signals in dyspnea, if any, is probably enhancement (17, 18) . Thus, it is unlikely that IPV decreased dyspnea by decreasing vagal afferent signals. In COPDpatients, upper inspiratory intercostal muscles are suggested to be tonically active during AE (9) , and may contribute to the increase in functional residual capacity (FRC) (19) . Increasing hyperinflation during leg exercise has been indicated to be related to dyspnea in COPDpatients (20) . Since IPV maystimulate the muscle spindles of the expiratory intercostal muscleduring the expiratory phase, elicit tonic vibration reflex (7) and decrease FRCat rest in COPDpatients (4), a decrease in FRCcould have also occurred with IPV and contributed to the decrease in dyspnea in the present study.
In conclusion, O2 desaturation may not be involved in AE dyspnea. The present study does not support O2 supplementation against dyspnea during arm elevation in patients with COPD.On the other hand, IPV specifically decreases dyspnea during AEwithout decreasing ventilation or improving blood gas. This effect may in part involve afferent signals from
